Institute of Human Virology at International HBV Meeting

The event also provided opportunities for early and mid-career researchers to strengthen professional communication skills, explore career development, and engage with leading experts in hepatitis B, hepatitis D, and liver cancer research.

READ MORE about Institute of Human Virology at International HBV Meeting

Sarah M. Kattakuzhy, MD, MPH is the 2025 UMBrella Person of the Year- On the Rise awardee.

Nominees for this award are in the early stage of their career, achieved growth in their career or overcame personal/professional challenges with the utilization of mentorship, coaching, and/or professional development opportunities.

READ NOW about Sarah M. Kattakuzhy, MD, MPH is the 2025 UMBrella Person of the Year- On the Rise awardee.

Institute of Human Virology (IHV)

Research Initiatives

‌IHV Research is Leading the Way Toward Innovative Therapies

IHV scientists and researchers are forging new paths in the fight against HIV and AIDS, the deadliest pandemic in modern medical history. The IHV is the first research institute in the U.S. to link basic science, population studies and clinical trials in an effort to develop new vaccines and treatments.

Patient Information

‌‌IHV is Providing Compassionate Cutting-Edge Care

The IHV serves approximately 5,000 patients through six Baltimore area clinics and more than 500,000 patients in seven African and two Caribbean nations. The IHV specializes in the treatment of HIV/AIDS and other chronic viral diseases, such as Hepatitis C, Hepatitis B, and the Human Papilloma Virus Infection.